Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events
IrAE-related hospitalization deteriorated the survival of ICI-treated patients, likely due to decreased biological efficacy of ICIs resulting from short therapy periods and strong immunosuppression by glucocorticoids.
Authors
- Outi Kuittinen (ORCID: https://orcid.org/0000-0001-9969-0053)
- Tuomas A. Selander (ORCID: https://orcid.org/0000-0002-0070-8565)
- Aino Rönkä (ORCID: https://orcid.org/0000-0001-6007-3648)
- Satu Tiainen (ORCID: https://orcid.org/0000-0002-5673-8851)
- Sanna Pasonen‐Seppänen (ORCID: https://orcid.org/0000-0002-7131-1338)
- Anni Juntunen
- Veera Nurmela
Institutions
- University of Eastern Finland (FI)
- Kuopio University Hospital (FI)
- Finland University (FI)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1080/1750743x.2025.2492541
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Kuopion Yliopistollinen Sairaala